NORTHERN TRUST CORP - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$6,185
-40.5%
29,7050.0%0.00%
Q1 2023$10,397
+62.8%
29,7050.0%0.00%
Q4 2022$6,387
-36.1%
29,7050.0%0.00%
Q3 2022$10,000
-75.0%
29,7050.0%0.00%
Q2 2022$40,000
-32.2%
29,705
+1.4%
0.00%
Q1 2022$59,000
-25.3%
29,2990.0%0.00%
Q4 2021$79,000
-37.3%
29,2990.0%0.00%
Q3 2021$126,000
+125.0%
29,299
+34.0%
0.00%
Q2 2021$56,000
+107.4%
21,873
+82.7%
0.00%
Q3 2020$27,00011,9740.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders